These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2642535)
1. Diazepam treatment of early symptoms of schizophrenic relapse. Kirkpatrick B; Buchanan RW; Waltrip RW; Jauch D; Carpenter WT J Nerv Ment Dis; 1989 Jan; 177(1):52-3. PubMed ID: 2642535 [TBL] [Abstract][Full Text] [Related]
2. Diazepam in schizophrenia: a preliminary double-blind trial. Jimerson DC; van Kammen DP; Post RM; Docherty JP; Bunney WE Am J Psychiatry; 1982 Apr; 139(4):489-91. PubMed ID: 7039369 [No Abstract] [Full Text] [Related]
3. Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms. Csernansky JG; Riney SJ; Lombrozo L; Overall JE; Hollister LE Arch Gen Psychiatry; 1988 Jul; 45(7):655-9. PubMed ID: 3289523 [TBL] [Abstract][Full Text] [Related]
4. Diazepam treatment of early signs of exacerbation in schizophrenia. Carpenter WT; Buchanan RW; Kirkpatrick B; Breier AF Am J Psychiatry; 1999 Feb; 156(2):299-303. PubMed ID: 9989567 [TBL] [Abstract][Full Text] [Related]
5. High dose diazepam in schizophrenia. Beckmann H; Haas S Psychopharmacology (Berl); 1980; 71(1):79-82. PubMed ID: 6779328 [TBL] [Abstract][Full Text] [Related]
6. Diazepam in a patient with chronic schizophrenia complicated by agoraphobia. Finkel JA J Clin Psychiatry; 1987 Jan; 48(1):33-4. PubMed ID: 3804985 [TBL] [Abstract][Full Text] [Related]
7. Liquid-chromatographic assay of diazepam and its major metabolites in serum, and application to pharmacokinetic study of high doses of diazepam in schizophrenics. Tada K; Moroji T; Sekiguchi R; Motomura H; Noguchi T Clin Chem; 1985 Oct; 31(10):1712-5. PubMed ID: 3930095 [TBL] [Abstract][Full Text] [Related]
9. High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients. Weizman A; Tyano S; Wijsenbeek H; Ben David M Psychopharmacology (Berl); 1984; 82(4):382-5. PubMed ID: 6427833 [TBL] [Abstract][Full Text] [Related]
10. Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. III. Relapse postponement or relapse prevention? The implications for long-term outcome. Curson DA; Barnes TR; Bamber RW; Platt SD; Hirsch SR; Duffy JC Br J Psychiatry; 1985 May; 146():474-80. PubMed ID: 3893600 [TBL] [Abstract][Full Text] [Related]
12. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study. Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069 [No Abstract] [Full Text] [Related]
13. Auditory hallucinations suppressed by etizolam in a patient with schizophrenia. Benazzi F; Mazzoli M; Rossi E Can J Psychiatry; 1993 Oct; 38(8):574-5. PubMed ID: 7902201 [TBL] [Abstract][Full Text] [Related]
14. Analgesic and euphoric effects of high dose diazepam in schizophrenia. Haas S; Emrich HM; Beckmann H Neuropsychobiology; 1982; 8(3):123-8. PubMed ID: 7078714 [TBL] [Abstract][Full Text] [Related]
15. Pavor nocturnus in a schizophrenic patient: a review and case study. McLeod MN; Fisher P Am J Psychiatry; 1978 Feb; 135(2):235-6. PubMed ID: 623343 [No Abstract] [Full Text] [Related]
16. Comparison of the sedative effects of diazepam given by the oral and intramuscular routes. McCaughey W; Dundee JW Br J Anaesth; 1972 Aug; 44(8):901-2. PubMed ID: 4563239 [No Abstract] [Full Text] [Related]
17. Diazepam in long-term chronic schizophrenia. Borelli N; Marjerrison G Am J Psychiatry; 1966 May; 122(11):1292-3. PubMed ID: 5325570 [No Abstract] [Full Text] [Related]